Cargando…

Maximizing the return on taxpayers' investments in fundamental biomedical research

The National Institute of General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of more than $2.3 billion. The institute uses these funds to support fundamental biomedical research and training at universities, medical schools, and other institutions across...

Descripción completa

Detalles Bibliográficos
Autor principal: Lorsch, Jon R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Cell Biology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436771/
https://www.ncbi.nlm.nih.gov/pubmed/25926703
http://dx.doi.org/10.1091/mbc.E14-06-1163
_version_ 1782372126943084544
author Lorsch, Jon R.
author_facet Lorsch, Jon R.
author_sort Lorsch, Jon R.
collection PubMed
description The National Institute of General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of more than $2.3 billion. The institute uses these funds to support fundamental biomedical research and training at universities, medical schools, and other institutions across the country. My job as director of NIGMS is to work to maximize the scientific returns on the taxpayers' investments. I describe how we are optimizing our investment strategies and funding mechanisms, and how, in the process, we hope to create a more efficient and sustainable biomedical research enterprise.
format Online
Article
Text
id pubmed-4436771
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The American Society for Cell Biology
record_format MEDLINE/PubMed
spelling pubmed-44367712015-07-16 Maximizing the return on taxpayers' investments in fundamental biomedical research Lorsch, Jon R. Mol Biol Cell Perspective The National Institute of General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of more than $2.3 billion. The institute uses these funds to support fundamental biomedical research and training at universities, medical schools, and other institutions across the country. My job as director of NIGMS is to work to maximize the scientific returns on the taxpayers' investments. I describe how we are optimizing our investment strategies and funding mechanisms, and how, in the process, we hope to create a more efficient and sustainable biomedical research enterprise. The American Society for Cell Biology 2015-05-01 /pmc/articles/PMC4436771/ /pubmed/25926703 http://dx.doi.org/10.1091/mbc.E14-06-1163 Text en “ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of the Cell®” are registered trademarks of The American Society for Cell Biology.
spellingShingle Perspective
Lorsch, Jon R.
Maximizing the return on taxpayers' investments in fundamental biomedical research
title Maximizing the return on taxpayers' investments in fundamental biomedical research
title_full Maximizing the return on taxpayers' investments in fundamental biomedical research
title_fullStr Maximizing the return on taxpayers' investments in fundamental biomedical research
title_full_unstemmed Maximizing the return on taxpayers' investments in fundamental biomedical research
title_short Maximizing the return on taxpayers' investments in fundamental biomedical research
title_sort maximizing the return on taxpayers' investments in fundamental biomedical research
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436771/
https://www.ncbi.nlm.nih.gov/pubmed/25926703
http://dx.doi.org/10.1091/mbc.E14-06-1163
work_keys_str_mv AT lorschjonr maximizingthereturnontaxpayersinvestmentsinfundamentalbiomedicalresearch